Despite salaries increasing by 4% on average, companies offering more paid time off and location flexibility winning the remote versus in-office workplace battle, American workers are more miserable now than they were during the pandemic.
In 2024, for the first time, the number of new cancer diagnoses in the U.S. is projected to exceed 2 million. This sobering statistic was revealed alongside other cancer trends in the American Cancer Society's new Cancer Facts & Figures 2024 report.
Menopause is hot right now—and more and more companies are adding menopause care to their employee benefits packages. But a successful menopause program depends on a few key factors.
Learn about Stop Loss industry claim trends, including the impact of gene and cell therapies, and how they are affecting claim costs for self-funded employers.
Biologics are one of the fastest growing category of drugs—and one of the most expensive—making it challenging to balance cost with safety and efficacy. And it's even more challenging to incorporate unbranded biologics and biosimilars into benefits plans.
The American Cancer Society announced changes to its lung cancer screening guidelines, expanding their recommendations to all people over 50 who smoked more than 20 packs per year, and removing the minimum requirement for 'years since quitting.'